ARCHIVES

ACS Study Shows Reduced Mortality For Low T/N Brands

This article is from The Cancer Letter archive.

Vol. 06 No. 16 | April 18, 1980

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Key In Long-Term Treatment

August 29, 2008

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

NCI Appropriations Still Hung Up

September 30, 1977

Moves Forward With Approval From BSA

November 22, 2013

White House FY 1979 Budget Probably Will give NCI $900 Million; NCAB Objects To ’78 Allocations

November 25, 1977